Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by MedStocks2on Aug 17, 2019 2:20am

58 Views

Post# 30039039

RE:RE:RE:RE:RE:House Positions; Market Summary; naysayers still present

Again, I am not moving on. I intend to hold by shares and provide a much needed dose of reality for all the pumpers on this board. I believe in the science but not so much in management and I have just as much right to post my points here as jball does to continue posting his nonsense pumps and smokescreens. Had anyone warned me about the bs that goes on with financing here, I would never have bought a single share on the open market.

Bullboard Posts

The top TSX healthcare stocks under $1